Fragmented care, such as receiving prescriptions from specialists without informing primary care providers, can further disrupt continuity in therapy
The review documented GHK-Cus ability to promote balanced collagen synthesis, accelerate epithelialisation, and reduce fibrosis in both in vitro and pre-clinical models
Brattstrm L, Landgren F, Israelsson B, Lindgren A, Hultberg B, Andersson A, Cuskelly G, McNulty H, Strain SS, McPartlin J, Weir DG, Scott JM, den Heijer M, Brouwer IA, Blom HJ, Bos GMJ, Spaans A, Rosendaal FR, Thomas CMG, Haak HL, Wijermans PW, Gerrits WBJ, Naurath HJ, and Joosten E (1998)
In 2020, it was estimated that gynecological cancers accounted for nearly 40% of all cancers diagnosed in women, contributing to 30% of all cancer-related mortality in this population [1,2]